Liver Angioma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Liver Angioma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07418294

Fluctuational Imaging for the Diagnosis of Hepatic Hemangioma: A Multicenter, Prospective Study

\[Background and Rationale\] Hepatic hemangioma is the most common benign tumor of the liver, with a reported prevalence of up to 20% in the general population.…

South Korea400 participantsStarted 2026-01-02

All recent trials (19 shown)

CompletedNot Applicable

NCT07153783

Interventional AI-Human Collaboration for Liver Tumor Diagnosis

Recent advances in artificial intelligence (AI), particularly deep learning technology, have transformed medical imaging analysis. AI systems have demonstrated…

China10,333 participantsStarted 2025-09-01

Treatment: AI-human collaboration for CE-CTs diagnosis

TerminatedPhase 1/2

NCT03633747

Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma

Hepatic hemangioma is one of the most common benign tumor of the liver. Although the overall prognosis is good, active interventions are still needed in high-ri…

China8 participantsStarted 2018-07-01

Treatment: Propranolol Hydrochloride

Liver Angioma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Fluctuational Imaging for the Diagnosis of Hepatic Hemangioma: A Multicenter, Prospective Study

All recent trials (19 shown)

Interventional AI-Human Collaboration for Liver Tumor Diagnosis

Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Fluctuational Imaging for the Diagnosis of Hepatic Hemangioma: A Multicenter, Prospective Study

All recent trials (19 shown)

Interventional AI-Human Collaboration for Liver Tumor Diagnosis

Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma

Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy

Clinical Characteristics of Infantile Hemangioma

Surgical Management of Giant Hepatic Hemangioma

Surgical Approach in Liver Hemangiomas

Percutaneous Sclerotherapy of Symptomatic Liver Hemangioma With Bleomycin

Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection

Impact of Sarcopenia on Postoperative Outcomes of Patients Undergoing Liver Resection

Percutaneous Ultrasound-guided "Three-step" Radiofrequency Ablation for Giant Hepatic Hemangioma

Contrast Enhanced (CE) Ultrasound and CE Computed Tomography or CE Magnetic Resonance Imaging in Liver Masses

Classical Procedure Versus Intrahepatic Glisson's Approach

Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors

The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver

Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy

A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver

Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial

Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver Lesions